Medicine and Dentistry
Clinical Prediction Model
100%
Percutaneous Coronary Intervention
92%
COVID-19
73%
Percutaneous Aortic Valve Replacement
71%
Cardiovascular System
69%
Acute Coronary Syndrome
37%
Heart Failure
34%
ST Segment Elevation Myocardial Infarction
34%
Odds Ratio
28%
Observational Study
27%
All Cause Mortality
25%
Malignant Neoplasm
24%
Frailty
24%
Cardiovascular Disease
23%
Cardiovascular Risk
23%
Acute Heart Infarction
22%
Mortality Rate
22%
Meta-Analysis
22%
Cohort Analysis
21%
Cancer Risk
20%
Hospital Mortality
20%
Health Inequality
20%
Primary Percutaneous Coronary Intervention
19%
Body Mass Index
19%
Prevalence
18%
Relative Survival
18%
Pneumonectomy
18%
Patient Referral
18%
Sepsis
18%
Chronic Total Occlusion
18%
Remote Sensing
18%
Non ST Segment Elevation Myocardial Infarction
18%
Triage
17%
Hazard Ratio
17%
Diabetes
16%
Diseases
16%
Aortic Stenosis
15%
Thorax Pain
13%
Adverse Event
13%
Population
12%
Aortic Valve Replacement
12%
Troponin
12%
Multiple Chronic Conditions
12%
Decision Making
12%
Logistic Regression Analysis
11%
Surgery
11%
Electronic Health Record
11%
High Risk Population
11%
Coronary Artery Disease
11%
Scoring System
10%
Pharmacology, Toxicology and Pharmaceutical Science
Heart Failure
36%
Cardiovascular Disease
36%
Acute Coronary Syndrome
34%
Malignant Neoplasm
34%
Mortality Rate
31%
Acute Heart Infarction
27%
Cohort Study
24%
Disease
22%
ST Segment Elevation Myocardial Infarction
20%
All Cause Mortality
19%
Thorax Pain
19%
Methotrexate
18%
Sepsis
18%
Coronavirinae
18%
Rheumatoid Arthritis
18%
Nonoxynol-9
18%
Hospital Mortality
18%
Multiple Chronic Conditions
18%
Obesity
18%
Survival Rate
18%
Infection
17%
Cardiovascular System Cancer
15%
Adverse Event
15%
Mortality
12%
Epileptic Absence
12%
Comorbidity
11%
Life Table
11%
Coronary Artery Disease
11%
Frailty
10%
Prospective Study
10%
Atherosclerosis
10%
Congestive Heart Failure
10%
Heart Infarction
10%
Cardiovascular Risk
9%
Bleeding
9%
Antibiotic Agent
9%
Case Fatality Rate
9%
Long Term Survival
9%
Fibrinogen Receptor Antagonist
9%
Dexamethasone
9%
Barrett Esophagus
9%
Gastrointestinal Disease
9%
Pneumonia
9%
Statin (Protein)
9%
Musculoskeletal Disease
9%
Rheumatic Disease
9%
Sodium Valproate
9%
Cancer Survival
9%
Thrombosis
9%
Cardiotoxicity
9%
Nursing and Health Professions
Percutaneous Coronary Intervention
74%
Hospital Readmission
25%
Acute Coronary Syndrome
23%
Logistic Regression Analysis
20%
Acute Heart Infarction
18%
Sexual Assault
18%
Patient Referral
18%
Chronic Total Occlusion
18%
Prevalence
14%
Treatment Outcome
12%
Rheumatoid Arthritis
12%
Sample Size
12%
Predictor Variable
11%
Troponin
10%
Against Medical Advice
10%
Thorax Pain
10%
Rotational Atherectomy
10%
Infection
9%
Disease
9%
Care Pathway
9%
Deep Vein Thrombosis
9%
Methotrexate
9%
Antibiotic Agent
9%
Primary Medical Care
9%
Analytic Method
9%
Hospital Setting
9%
Heart Surgery
9%
Gastrointestinal Disease
9%
Electrocardiogram
9%
Frailty
9%
Critical Appraisal
9%
Dexamethasone
9%
APACHE
9%
Pneumonia
9%
Medical Examination
9%
Sexual Violence
9%
Meta Analysis
9%
Intensive Care
9%
Barrett Esophagus
9%
Quality Control
9%
Genital Injury
9%
K Nearest Neighbor
9%
Hospital Mortality
9%
Valproic Acid
9%
Confidence Interval
8%
Odds Ratio
7%
Healthcare System
7%
Embase
7%
Medline
7%
Injury
7%